SARS-CoV-2-IN-79
SARS-CoV-2-IN-79 (Compound 5) is a SARS-CoV-2 inhibitor, with IC50 and CC50 values of 55 μg/mL and 311.6 μg/mL. SARS-CoV-2-IN-79 has the highest antiviral activity against (hCoV-19/Egypt/NRC-03/2020) . SARS-CoV-2-IN-79 can be used for the research of COVID-19[1].
Product Specifications
UNSPSC
12352005
Target
SARS-CoV
Type
Reference compound
Related Pathways
Anti-infection
Applications
COVID-19-anti-virus
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/sars-cov-2-in-79.html
Solubility
10 mM in DMSO
Smiles
N=C1C(C2=NN=C(O2)C3=CN=CC=C3)=CC4=C(C=CC=C4)O1
Molecular Formula
C16H10N4O2
Molecular Weight
290.28
References & Citations
[1]Hashem HE, et al. In silico and in vitro prediction of new synthesized N-heterocyclic compounds as anti-SARS-CoV-2. Sci Rep. 2024 Jan 11;14 (1) :1152.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
GTR15318400 1 Vial
Lentiviral human DNAJA2 shRNA (UAS) - Lentiviral human DNAJA2 shRNA (UAS, RFP) plasmid
Ask
View Details 135247 100 µL
VGLL3 (Transcription Cofactor Vestigial-like Protein 3, VGL3, Vgl-3) (Not for Export EU)
Ask
View Details